Cargando…
Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification
Calcific aortic valve disease (CAVD) accompanies inflammatory cell infiltration, fibrosis, and ultimately calcification of the valve leaflets. We previously demonstrated that dipeptidyl peptidase-4 (DPP-4) is responsible for the progression of aortic valvular calcification in CAVD animal models. As...
Autores principales: | Choi, Bongkun, Kim, Eun-Young, Kim, Ji-Eun, Oh, Soyoon, Park, Si-On, Kim, Sang-Min, Choi, Hyuksu, Song, Jae-Kwan, Chang, Eun-Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824080/ https://www.ncbi.nlm.nih.gov/pubmed/33401457 http://dx.doi.org/10.3390/cells10010057 |
Ejemplares similares
-
Aortic valve calcification – the role of inflammation and fibrosis
por: Pissaridi, K, et al.
Publicado: (2013) -
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis
por: Lee, Sahmin, et al.
Publicado: (2020) -
Sphingosine-1-phosphate hinders the osteogenic differentiation of dental pulp stem cells in association with AKT signaling pathways
por: Choi, Bongkun, et al.
Publicado: (2022) -
Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
por: Shin, Yesong, et al.
Publicado: (2022) -
Hemodynamics and Mechanobiology of Aortic Valve Inflammation and Calcification
por: Balachandran, Kartik, et al.
Publicado: (2011)